HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials.

AbstractOBJECTIVE:
To systematically evaluate and quantify the effects of rotigotine treatment on neuropsychiatric symptoms in Parkinson's disease (PD).
METHODS:
We searched for articles involving randomized controlled trials (RCTs) that were published before September 1, 2017, in the PubMed, Clinical Trials, Cochrane Library, and EMBASE databases. A meta-analysis was performed to estimate changes in the scales used to assess neuropsychiatric symptoms. The data were analyzed using Cochrane Collaboration's Review Manager 5.3 software.
RESULTS:
We identified 8 RCTs involving 1675 subjects. Compared with placebo treatment, treatment with the rotigotine transdermal patch significantly improved scores for the emotion/apathy domains of the Non-Motor Symptoms Scale (NMSS), Beck Depression Inventory-II (BDI-II), Apathy Scale (AS), the sleep/fatigue domains of the NMSS, the 8-item Parkinson's disease Questionnaire (PDQ-8) and the 39-item PDQ (PDQ-39) (emotion/apathy domain of the NMSS: MD = -2.5, 95% CI [-4.11, 0.89]; BDI-II: MD = -1.19, 95% CI [-2.30, 0.08]; AS: MD = -1.56, 95% CI [-2.67, 0.45]; sleep/fatigue domain of the NMSS: MD = -2.03, 95% CI [-3.08, 0.98]; PDQ-8: MD = -4.93, 95% CI [-6.79, 3.07]; PDQ-39: MD = -3.52, 95% CI [-5.25, 1.79]; PDQ-8 and PDQ-39: SMD = -0.36,95% CI [-0.49,0.23]). The results of the Parkinson's Disease Sleep Scale 2nd version (PDSS-2) were heterogeneous, and those on the Snaith-Hamilton Pleasure Scale (SHAPS) were not statistically significant (P = .61).
CONCLUSION:
The rotigotine transdermal patch effectively improved neuropsychiatric symptoms and quality of life in patients with PD. Further studies are warranted.
AuthorsHao-Tian Wang, Li Wang, Yi He, Gang Yu
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 393 Pg. 31-38 (10 15 2018) ISSN: 1878-5883 [Electronic] Netherlands
PMID30099246 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • Dopamine Agonists
  • Psychotropic Drugs
  • Tetrahydronaphthalenes
  • Thiophenes
  • rotigotine
Topics
  • Dopamine Agonists (administration & dosage)
  • Humans
  • Mental Disorders (drug therapy, etiology)
  • Parkinson Disease (drug therapy, psychology)
  • Psychotropic Drugs (administration & dosage)
  • Randomized Controlled Trials as Topic
  • Tetrahydronaphthalenes (administration & dosage)
  • Thiophenes (administration & dosage)
  • Transdermal Patch

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: